Head and Neck Carcinoma, Other — Trials

Head and Neck Carcinoma, Other — Trials · CancerIndex

Clinical trials

Registered studies

128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 35
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07713901	Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma	enrolling by invitation	—	93,600,000	Novo Nordisk A/SINDUSTRY	1	Aug 4, 2026	clinicaltrials
NCT06852144	PET-TC in Thyroid Evaluation(PEPATI-MN-2024)	enrolling by invitation	—	418	IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER	1	Feb 28, 2025